The nation of Zimbabwe has rejected a substantial American healthcare agreement worth $367m (272 million pounds) over five years due to Washington's demand for sensitive data.
The decision came to light after a government memo dated December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the deal was "skewed".
An official spokesman later explained that the US was demanding access to health data for scientific study and commercial gain while was unwilling to share the benefits from any future vaccines.
"We will now turn to the difficult and regrettable process of scaling back our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had donated more than $1.9bn in health funding to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has appealed for further dialogue to reach a deal agreeable to all parties so the nation's critical HIV programme can proceed.
Wider Implications
Zimbabwe's decision follows a comparable situation in neighbouring Kenya, where a court halted a related deal with the US following legal challenges were raised about the security of citizens' medical information.
Since returning to office last year, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).
USAID had administered aid for the US government, but Trump stated its expenditure was "inefficient" and his government was seeking direct bilateral deals to boost transparency and accountability.
According to statements, 16 nations in Africa have to date agreed to these new health pacts, representing over $18.3bn in new funding.
Details of the Declined Agreement
The money for Zimbabwe was intended to gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation could have provided extraordinary benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently on antiretroviral therapy through US-supported initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana argued the arrangement was "unequal".
"The proposal required Zimbabwe to share its biological resources and data for a long time, with no equivalent guarantee of benefiting from any scientific breakthroughs – such as new medicines or tests – that could result from that provided information," he stated.
"In essence, our nation would provide the basic resources for medical research without any certainty that the resulting innovations would be available to our population if a future disease outbreak arise."
Sovereignty and International Frameworks
He also noted that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were undermining frameworks already set up through the global organization.
Mangwana gave as an example its Pandemic Benefit-Sharing system designed to deal with potential global health emergencies.
"This system is designed to ensure that when a country contributes its data, the benefits – including medicines and cures – are distributed fairly, not commercialised solely by those with the capability to develop them."
These objections regarding the US deal "are not meant as hostility towards the US," he added.
"We are open to ongoing discussions with our US partners on how future co-operation might be structured in a way that honours the sovereignty and interests of both nations."
Health Experts Response
A leading public health body expressed it acknowledged the government's concerns, but suggested that negotiations need to persist since much of the nation's HIV programmes were funded by external financing.
"If technical issues arise, such as those relating to data governance or implementation frameworks, these can often be resolved through detailed discussion and negotiated safeguards," it said.
The situation highlights the continuing tensions between receiving vital foreign assistance and protecting local interests in an increasingly interconnected world.